Literature DB >> 33872853

ADHD symptoms as risk factor for PTSD in inpatients treated for alcohol use disorder.

Ingeborg Bolstad1, Lars Lien2, Jørgen G Bramness3.   

Abstract

Attention deficit hyperactivity disorder (ADHD) and post-traumatic stress disorder (PTSD) are more common in alcohol use disorder (AUD) patients than in the general population. Still, there is a lack of knowledge about the relationship between the two conditions in these patients. The main objective of this study was to examine the prevalence of ADHD symptoms, and the relationship between ADHD symptoms and PTSD in AUD inpatients in treatment. Data from 85 AUD patients were collected. The Adult ADHD Self-Report Scale (ASRS) was used to measure ADHD symptoms in all patients. Differences between groups split by PTSD diagnosis and by ASRS clinical cut-off were described, and the relationship between ADHD symptom level and PTSD was tested in a multiple regression model. Almost half the patients scored above ASRS cut-off and 14% had PTSD. Of the patients whose score was above cut-off on the ASRS 23% had PTSD, versus 7% among those below cut-off. Higher ASRS score was associated with PTSD even when age, sex and trauma were adjusted for. This study confirms the high level of ADHD symptoms in AUD patients in treatment. Diagnostic evaluation of PTSD is recommended in patients with ADHD attending inpatient treatment programs for AUD.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Adult ADHD self-report scale; Alcohol dependence; Alcohol use disorder; Attention deficit hyperactivity disorder; Post-traumatic stress disorder

Year:  2021        PMID: 33872853     DOI: 10.1016/j.psychres.2021.113904

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  1 in total

1.  History of Delirium Tremens in AUD Patients in Treatment: Relationship to AUD Severity and Other Factors.

Authors:  Jørgen G Bramness; Susmita Pandey; Jenny Skumsnes Moe; Helge Toft; Lars Lien; Ingeborg Bolstad
Journal:  Subst Abuse Rehabil       Date:  2022-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.